Free Trial
CVE:MJN

Cronos Group (MJN) Stock Price, News & Analysis

Cronos Group logo
C$12.15 -0.23 (-1.86%)
As of 03/2/2018

About Cronos Group Stock (CVE:MJN)

Key Stats

Today's Range
C$11.90
▼
C$12.47
50-Day Range
C$12.15
▼
C$12.15
52-Week Range
C$1.58
▼
C$14.83
Volume
1.39 million shs
Average Volume
2.07 million shs
Market Capitalization
C$1.73 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Cronos Group Inc, formerly PharmaCan Capital Corp, is a Canada-based cannabis company. The Company operates two Licensed Producers (LPs) regulated within Health Canada's Access to Cannabis for Medical Purposes Regulations (the ACMPR) and holds a portfolio of investments in other Licensed Producers and ACMPR applicants. Its LPs, Peace Naturals Project Inc. and In The Zone Produce Ltd., are collectively located on over 125 acres of agricultural land. It also holds equity positions in Licensed Producers Whistler Medical Marijuana, Hydropothecary and Abcann Medicinals. Whistler Medical Marijuana is licensed to produce and sell medical marijuana, as well as cultivate cannabis oil. Hydropothecary is licensed to produce medical marijuana. Abcann Medicinals also has license to produce medical marijuana. With interest in five Licensed Producers and two LP applicants, it is focused on building brand portfolio providing patients with personalized care.

Receive MJN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MJN Stock News Headlines

My next big call (under $1)
Bitcoin is down. Fear is high. Most investors are sitting on their hands. That's exactly when my biggest winners have been found: KDA: 17,556% ... PRE: 3,900% ... OCEAN: 2,650% ... ALBT: 1,933% Every single one was called to our community before the big move happened. So today, while everyone else is scared, I'm making my next big call.tc pixel
See More Headlines

MJN Stock Analysis - Frequently Asked Questions

Cronos Group's stock was trading at C$12.15 at the start of the year. Since then, MJN shares have increased by 0.0% and is now trading at C$12.15.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cronos Group investors own include Canopy Growth (CGC), Cronos Group (CRON), Aurora Cannabis (ACB), Canopy Growth (WEED), Organigram (OGI), Aphria (APHA) and IMV (IMV).

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
CVE:MJN
CIK
N/A
Fax
N/A
Employees
7,600
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
142,653,000
Free Float
N/A
Market Cap
C$1.73 billion
Optionable
Not Optionable
Beta
N/A
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (CVE:MJN) was last updated on 3/2/2018 by MarketBeat.com Staff.
From Our Partners